Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D05HIG | ||||
| Former ID | DNC013791 | ||||
| Drug Name | 6-Phenylhexylcarbamic Acid Biphenyl-3-yl Ester | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [529498] | ||
| Formula | C25H27NO2 | ||||
| Canonical SMILES | C1=CC=C(C=C1)CCCCCCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 | ||||
| InChI | 1S/C25H27NO2/c27-25(26-19-10-2-1-5-12-21-13-6-3-7-14-21)28-24-18-11-17-23(20-24)22-15-8-4-9-16-22/h3-4,6-9,11,13-18,20H,1-2,5,10,12,19H2,(H,26,27) | ||||
| InChIKey | MGXPWHVQDGCMAC-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
